Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation.
Inflammation has classically been defined histopathologically, especially by the presence of immune cell infiltrates. However, more recent studies suggest a role for "low-grade" inflammation in a variety of disorders ranging from metabolic syndrome to cancer, which is defined by modest ele...
Main Authors: | Benoit Chassaing, Gayathri Srinivasan, Maria A Delgado, Andrew N Young, Andrew T Gewirtz, Matam Vijay-Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3434182?pdf=render |
Similar Items
-
Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency.
by: Benoit Chassaing, et al.
Published: (2018-01-01) -
Microbiota-Inducible Innate Immune Siderophore Binding Protein Lipocalin 2 Is Critical for Intestinal HomeostasisSummary
by: Vishal Singh, et al.
Published: (2016-07-01) -
Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat DietâInduced Liver DiseaseSummary
by: Lucie Etienne-Mesmin, et al.
Published: (2016-09-01) -
Data on importance of hematopoietic cell derived Lipocalin 2 against gut inflammation
by: Piu Saha, et al.
Published: (2016-09-01) -
Dietary Emulsifiers Directly Impact Adherent-Invasive E. coli Gene Expression to Drive Chronic Intestinal Inflammation
by: Emilie Viennois, et al.
Published: (2020-10-01)